Most New Zealand soils contain relatively low concentrations of the anionic trace elements F, I and Se. This, in part, has highlighted the risks of deficiency, and has led to considerable research on nutritional aspects of these trace elements in New Zealand (Robinson, 1989 (Robinson, , 1992 ; Thomson & Robinson, 1996) . I-deficiency goitre was very common in the late 1800s and early 1900s before the iodization of salt in 1924. Some parts of Australia also have a history of I deficiency (Stewart et al. 1971; Gibson, 1995) . There is little evidence, however, that Se nutrition is inadequate in Australia, and the importation of Australian wheat with relatively high Se concentrations may have prevented potential Se deficiency in some parts of New Zealand. In view of current interest in establishing reference nutrient intakes for Se and I in Australasia, it is timely to review current understanding of the intakes and status of these two elements.
Selenium intakes in New Zealand and Australia

Food sources of selenium
Food is the major source of Se, with drinking water and air being minor contributors (Barceloux, 1999) . Dietary intake varies with the geographical source of the foods and the eating habits of the local populations. Soil Se concentrations around the world typically range from , 0·01 mg/ g in Se-deficient areas to . 1000 mg/g elsewhere. Plantfood concentrations roughly reflect the Se concentration of the soils in which plants are grown. Hence, dietary intakes around the world can range from , 10 mg/d in the low soil-Se areas of China where Keshan disease is endemic (Yang et al. 1983) to 20 -60 mg in New Zealand Russell et al. 1999 ) and up to 5000 mg/d in seleniferous areas of China (Yang et al. 1983) . Some plant foods are particularly high in Se, including Brazil nuts and mushrooms Vannoort et al. 2000) .
Variability in Se concentrations is less evident in animal foods: fish and organ meats are the richest sources followed by muscle meats, but the bioavailability of Se is greatest from Se-enriched yeast, cereals and grains. Dairy products, fruits and vegetables tend to be the poorest sources of Se . In New Zealand Vannoort et al. 2000) and Australia (Fardy et al. 1989 (Fardy et al. , 1994 Tinggi et al. 1992; Tinggi, 1999) the main sources of Se in the diet are seafood, poultry and eggs, and to a lesser extent other muscle meats. The contribution of cereals to dietary Se intakes varies with the source of the crop.
Selenium intakes in New Zealand
Se intakes in New Zealand have increased during the past 10 years, due largely to an increase in the importation of Australian wheat and other cereal products and to an increased use of supplemental Se in animal feeds in New Zealand (Thomson & Robinson, 1996) . Early studies indicated mean Se intakes, determined from duplicate diets, were , 30 mg/d (Robinson & Thomson, 1987) . Even in 1999, intakes as low as 28 mg/d (determined by duplicate diets and diet records) were found in Dunedin residents with low Se status and who had been asked not to consume high-Se foods such as fish, liver, kidney and Brazil nuts . A recent study of Dunedin smokers showed mean intakes from diet records of 56 mg/d for male and 38 mg/d for female subjects (Paterson, 2000) . Similar intakes, determined by 24 h recall, were reported from the New Zealand National Nutrition Survey (Russell et al. 1999) . Median intakes were 56 (10th percentile 36, 90th percentile 91) mg/d and 39 (10th percentile 25, 90th percentile 68) mg/d for male and female subjects respectively. Se intakes in nonbreast-fed infants and toddlers, determined using diet records, were 7·9 (SD 6·2) and 13·7 (SD 8·4) mg/d respectively (McLachlan, 2003) , while those estimated from 5-15-year-old children from the pilot pre-test of the Children's Nutrition Survey using a computerized 24 h recall, were 34 (SD 24) mg/d (Scragg & Metcalf, 2001) (Table 1) .
The New Zealand Food Composition Database for Se, however, may not be sufficiently accurate to reliably estimate Se intakes because of the regional variation of Se concentrations in bread and other wheat products. This is due to the greater use of Australian wheat (100 %) in bread-making in the north of the North Island, while in the South Island all wheat used is normally grown locally. In the south of the North Island about 30-35 % of wheat used is Australian (N Athar, New Zealand Institute of Crop and Food Research, personal communication) . A further factor is that some bread manufactured in the North Island is distributed in the South Island. The 1997 -98 New Zealand Total Diet Survey found Se concentrations in white bread of about 25 mg/kg in Dunedin and Christchurch (South Island), 80-104 mg/kg in Napier (mid-east of the North Island) and 78-114 mg/kg in Auckland (north of the North island). The mean value for New Zealand, from which intake data for the country are calculated, is 59 mg/kg (Vannoort et al. 2000) . Intakes were derived from the 1997-98 Total Diet Survey; this involved sampling 114 different foods, of which 105 were considered to be those most commonly consumed by the majority of New Zealanders, and simulation of diets from available data on food consumption patterns. Estimated intakes were somewhat higher than those measured by dietary assessment methods, with mean intakes of 78 -82 mg/d in male subjects, 55 mg/d in female subjects and 25 -30 mg/d in children (Vannoort et al. 2000) .
Selenium intakes in Australia
There has been only limited study of dietary Se intakes in Australia (Tinggi, 2003) . Estimates of Australian Se intakes from the National Market Basket Survey in which fifty representative foods from each of the State capitals were analysed, and combined according to hypothetical diets, were 87 mg/d for adult male subjects, (Fardy et al. 1989) . These estimates are similar to those obtained in a study of Brisbane residents: 89 and 59 mg/d for adult male and female subjects respectively, and 56 mg/d for children (Reilly, 1993) . Se intakes were also assessed in the 1994 Australian Market Basket Survey, but are not included because values were expressed per kg body weight (Marro, 1996) . In another study the mean Se intake of ninety-seven preschool children aged 4 -6 years, measured by food-frequency questionnaire and 24 h recall, was 56 (SD 18) mg/d (Reilly et al. 1991 , 2000) . Further country comparisons may be found in the comprehensive review compiled by Combs (2001) , although values for England and New Zealand may now be out of date.
Selenium status in New Zealand and Australia
Assessment of selenium status
Blood Se concentration is generally considered a useful measure of both Se status and intake, but other tissues such as hair and toenails are also often assessed (Burk & Levander, 1999; Sheehan & Halls, 1999) . Plasma or serum Se reflects short-term status (several days); erythrocyte Se reflects longer-term status (several weeks to months). There are no internationally accepted 'normal' reference ranges because of variations in Se status from country to country. Tissue concentrations of Se are likely to be unreliable indicators, however, as they do not accurately reflect the functional activity, which varies with the form of Se ingested (Nève, 1991 (Nève, , 1995 Thomson et al. 1993) . Measurement of individual selenoproteins such as the Se-containing enzyme glutathione peroxidase (GPx), provides more accurate and useful information than does total Se alone (Patching & Gardiner, 1999) . The close relationship between plasma GPx (GPx-3) or erythrocyte GPx (GPx-1) activity and Se concentration is useful for assessment in individuals with relatively low status, but not beyond the maximal activity of the enzyme, i.e. blood Se greater than about 1·27 mmol (100 mg)/l (Rea et al. 1979) . It is often difficult, however, to compare results of GPx activities from different laboratories because of variations in methodology. Other selenoproteins such as selenoprotein P may be used, but simple assays are not yet available. Currently, plasma or serum Se is still the favoured measure of Se status for international comparisons.
Selenium status of New Zealanders
The relative paucity of Se in New Zealand soils has spurred the study of the significance of Se in human nutrition. In the 1950s white muscle disease and ill thrift in cattle and sheep in certain regions was found to be due to Se deficiency in soils. Subsequently, over the last 30 years, extensive investigations of the Se status of New Zealanders, the consequences of low Se status, Se metabolism, and the effects of supplementation of the diet with Se have been conducted in our laboratory. All investigations indicate that the Se intake and status of New Zealand residents is low (Griffiths & Thomson, 1974; Robinson, 1989; Thomson & Robinson, 1996; , and since supplementation results in an increase in GPx and selenoprotein P (Thomson et al. 1982 (Thomson et al. , 1985 (Thomson et al. , 1993 Thomson & Paterson, 2001) . In spite of this, no clinical signs of deficiency in New Zealand have been identified, apart from in one patient on total parenteral nutrition (van Rij et al. 1979 ). This may be due partly to the lack of specific clinical markers of Se deficiency. Other studies in New Zealand have confirmed the low Se status and have suggested a link with a number of conditions, such as CVD (Kay & Knight, 1979) and respiratory complications of premature newborn infants (Darlow et al. 1995) . Several reports suggest that blood Se concentrations of residents of the South Island of New Zealand have increased during the past 10 years due in part to greater importation of Australian wheat and other cereal products (Winterbourne et al. 1992; Thomson & Robinson, 1996) . The impact of wheat importation into New Zealand, however, is inconsistent as little Australian wheat is used in the South Island. The increase in Se status is likely to be due also to other factors such as the supplementation of animal feeds leading to higher concentrations in meat and poultry (Vannoort et al. 2000) , and also to changes in dietary patterns such as greater use of multigrain breads and imported legumes and nuts. Nevertheless, recent studies indicate that the Se status of the New Zealand population remains low compared with the population of many other countries, and may still be considered marginal (Table 2) . This view is supported by a response of increased levels of the functional selenoproteins, GPx and plasma selenoprotein P to Se supplementation ; CD Thomson, E Paterson and AM Grant, unpublished results). The current plasma Se levels of residents of the Otago region of the South Island are in the range 0·76 -1·65 mmol (60 -130 mg)/l, but there is inadequate data from other areas of New Zealand to estimate a 'normal' reference range for the country. Mean blood Se concentrations in residents of two North Island provincial regions, Waikato and Taranaki, were 1·08 mmol (85 mg)/l plasma and 1·38 mmol (109 mg)/l whole blood in 1994 compared with those from Otago residents in the same year of 0·90 mmol (71 mg)/l and 1·14 mmol (90 mg)/l respectively (Colls, 1996) . Thus, the national mean value is likely to be higher than that for Otago. Table 2 summarizes plasma and whole blood Se concentrations in New Zealand subjects obtained as baseline measures in various studies from 1992. Earlier values for blood Se concentrations in Otago residents from 1972 (plasma Se ranging from 0·56 (SD 0·14) to 0·89 (SD 0·13) mmol/l) and residents of other New Zealand cities have been summarized by Thomson & Robinson (1996) .
Selenium status of Australians
There is little information on the Se status of Australian populations. Dietary surveys in Australia have not included Se status. Mean Se concentrations reported in whole blood of Sydney workers in 1989 were 1·37 and 1·35 mmol (105 and 108 mg)/l for male and female subjects respectively (Fardy et al. 1989) , while in Adelaide a mean a value of 1·54 mmol (122 mg)/l for blood Se was reported by Judson (1987 -88) . Plasma Se in nineteen adults from Adelaide and twenty-five adults from Tasmania in 1990 was 1·11 (SD 0·25) and 0·97 (SD 0·16) mmol (88 (SD 20) and 77 (SD 13) mg)/l respectively (Daniels et al. 2000) , and in children aged # 1 -14 years, 0·82 (S 0·15) mmol/l (Reilly et al. 1990 ). These few reports indicate that blood Se levels, with a mean estimate for plasma of 1·12 mmol (94 mg)/l (Lyons et al. 2003) , were generally greater than those of New Zealanders.
Iodine intakes in New Zealand and Australia
Food sources of iodine
The major sources of I are seafood, iodized salt (NaCl), milk and eggs, while meat and cereals are secondary sources (Kidd et al. 1974; Vannoort et al. 2000) . Foods of marine origin (sea fish and shellfish, sea-meal (custard made of ground seaweed) and seaweeds) are rich in I, reflecting the much higher I concentration in seawater compared with most freshwaters (Kidd et al. 1974) . The I content of plants and animals depends on the environment in which they grow. Vegetables, fruits and cereals grown in soils with low I content are poor sources of I. Different cooking procedures produce varying levels of I loss, depending on cooking time, temperature and the nature of the food being cooked (Wang et al. 1999) . The greatest losses occur as a result of leaching into water during boiling (Goindi et al. 1995) .
In addition, there are adventitious sources of I including iodates in bread, iodophors (used as cleaning agents in the dairy industry) in dairy products and I-containing food colours (Gibson, 1990) . Iodophors have been used in the dairy industry in New Zealand and also in Australia, since 1962, for sanitizing milking machines and other equipment (Twomey, 1968; Joerin & Bowering, 1972; Eastman, 1999) . Kelp tablets and drugs, beverages (raspberry drinks) and products such as maraschino cherries often contain the food colouring erythrosine, a component of which is I. The bioavailability of I from erythrosine is, however, probably low (Wenlock, et al. 1982; Sumar & Ismail, 1997) .
Iodized salt probably remains an important source of I in the diets of New Zealanders. There are no data, however, Thomson & Robinson (1996) . † Screened for low Se status.
on its contribution to total I intake, due to the fact that estimates of discretionary salt intakes in the New Zealand population are not available. Estimates from other countries are derived from calculations for household salt purchases; these calculations do not take into account salt used for other purposes, such as in preservation and cleaning, and salt lost in cooking water (Bull & Buss, 1980 2002 ). It appears likely that recommendations to reduce salt intake, if adopted by an increasing number of New Zealanders, could exacerbate the risk of suboptimal I status, especially since non-iodized salt is used commercially in food manufacturing. In Australia, as little as 10 % of the population may be using iodized salt in the home because of the availability of non-iodized salt in supermarkets (Li et al. 2001) .
Iodine intakes in New Zealand
Most soils in New Zealand are relatively low in I, resulting in low concentrations in locally produced foods. Goitre was endemic in many parts of New Zealand in the late 1800s and early 1900s. As with other trace elements, the nutritional status of I in the New Zealand population may be influenced by changes in food supply, location of production and the amounts and origins of imported foods. In recent years I in dairy products has made a major contribution to the daily intake as a result of iodophor contamination (Joerin & Bowering, 1972; Sutcliffe, 1990) , which has raised the I intake of fullfat milk and dairy-product users. In 1972, the level of I in milk from farms in New Zealand using iodophors ranged from 10-750 mg/l, compared with 30 -110 mg/l from farms that did not use iodophors (Joerin & Bowering, 1972) . Sometimes intakes were raised to undesirable levels close to 1000 mg/d, compared with the recommended intake of 150 mg/d (Robinson, 1992) . Some intakes, where kelp tablets or I containing medications were taken regularly, approached the potentially harmful level of 2000 mg/d.
During the 1980s iodophors started to be replaced in the New Zealand and Australian dairy industries by other cleaning compounds, such as quaternary ammonium compounds, resulting in decreased I levels in milk and dairy products (Sutcliffe, 1990; Knowles et al. 1997) . Overall there has been a reduction in I intakes in New Zealand since monitoring began in 1982. Intakes estimated in the 1997-98 New Zealand Total Diet Survey from simulated diets were 84 -93 mg/d for male and 65-67 mg/d for female subjects (Vannoort et al. 2000) . These intakes did not take into account the addition of discretionary salt used during cooking or added at the table. The contribution of dairy products to total I intake remains relatively high: 42 % of the intake of a young male and 68 % of that of a 1-3-year-old child Vannoort et al. 2000) . The reduction in I intakes also reflects other dietary changes, such as the increased use of ready-to-eat and bought prepared foods (which contain non-iodized salt) and a probable decrease in the use of salt in cooking and at the table. I intake was not assessed in the 1997 National Nutrition Survey because of inadequate food composition data. Analysis of 3 d duplicate diets collected in a recent study of fifty Otago residents indicated intakes ranging from 12 to 812 (median 108) mg/d (CD Thomson, unpublished results) . These diets included discretionary salt used in cooking, but may not have included all salt used at the table.
Since most I is excreted in urine, daily I intake may be estimated from 24 h urinary iodide excretion on the assumption that 80 -90 % of I ingested is excreted. Thus, I intakes of 60-95 mg/d were estimated for North and South Island blood donors (Thomson et al. 1997a ), 60-70 mg/d for pregnant and lactating New Zealand women ) and 100 mg/d for a group of Otago residents in 1997. Such intakes are considerably less than the 200 mg/d recommended by the Nutrition Taskforce (Department of Health, 1991) and the 150 mg/d recommended in most countries (Food & Nutrition Board Institute of Medicine, 2001; Thomson, 2002) . The low intakes of pregnant women are of particular concern in view of the role of I in fetal brain development and the possible impact of inadequate I on psychomotor performance.
Iodine intakes in Australia
Little information is available on I intakes in Australia. Intakes cannot be estimated from surveys of daily urinary excretion as random urine samples only have been collected so far (Eastman, 1999; Gunton et al. 1999; Hynes, 2001; Li et al. 2001) . Several recent surveys of schoolchildren, healthy adults, pregnant women and diabetic patients report that urinary I excretion of Australians is decreasing (Gunton et al. 1999; Hynes, 2001; Li et al. 2001) . Thus, I intakes are probably also decreasing. As in New Zealand, the principal source of I in Australia has been from dairy products as a result of contamination by iodophors (Connolly, 1971) , and in Tasmania, from bread as a result of the addition of potassium iodate to improve the flour (Eastman, 1993) . A decrease in I intakes in Australia, as in New Zealand, is probably due to reduction in the use of iodophors in the dairy industry and decreasing iodized salt consumption (Eastman, 1999; Gunton et al. 1999) . Li et al. (2001) reported that as little as 10 % of the Australian population currently purchases iodized salt for domestic use. The Tasmanian State Government adopted the addition of iodate to bread as an I supplement in 1966, but this is no longer mandatory due to an increase in I-induced thyrotoxicosis. In October 2001, the Department of Health and Human Services of Tasmania introduced an intervention to increase intakes of I by 50 mg/d (Department of Health & Human Services, 2001) . To achieve this the Department has negotiated a memorandum of understanding with the bread manufacturers for them to use iodized salt (40 mg I/kg NaCl) for bread manufacture.
Iodine status in New Zealand and Australia
Assessment of iodine status
Daily urinary excretion of iodide closely reflects I intake, as only a small fraction is excreted in faeces. Thus, urinary iodide excretion in a 24 h urine specimen is used as an index of I nutriture (Hetzel & Dunn, 1989; Gibson, 1990; Dunn et al. 1993) . Twenty-four h urine collections are preferable, but are not practical for large field surveys where I deficiency is being assessed. Non-fasting casual urine specimens are usually obtained in such cases. Casual urine samples, however, are not suitable for estimating iodide excretion of individuals, even when expressed as the iodide:creatinine ratio (Nicolau et al. 1989; Thomson et al. , 1997a . First-voided fasting morning urine samples or double-voided fasting samples are sometimes collected, as these are less affected by immediately preceding intakes of I. These measures correlate better with 24 h iodide excretion than do non-fasting urine samples (Thomson et al. , 1997b . In populations with adequate general nutrition, urinary iodide concentration correlates well with the urinary iodide:creatinine ratio, so urinary iodide excretion relative to creatinine may be determined on the assumption that creatinine excretion is constant over time. There is some disagreement, however, about the suitability of the iodide:creatinine ratio for assessing I status (Furnée et al. 1994; Remer & Manz, 1994; Thomson et al. , 1997a Rasmussen et al. 1999) . Creatinine excretion increases with age until adulthood due to increases in muscle mass and creatinine production (Remer & Manz, 1994) , and is also influenced by malnutrition, strenuous exercise, fever and trauma (Gibson, 1990) . In surveys for assessing I deficiency within a population, iodide concentration in casual urine samples appears to be adequate (Frey et al. 1978) .
Iodine status of New Zealanders
Surveys during the 1960s to 1980s indicated more than adequate I intakes as measured by urinary iodide excretion (North & Fraser, 1965; Cooper et al. 1984; Simpson et al. 1984) . Median urinary iodide excretions in these surveys ranged from 202 mg/d in Wellington in 1965 (North & Fraser, 1965) , to 266 and 216 mg/d in Otago male and female subjects (with those on a salt-restricted diet 228 and 190 mg/d respectively; Simpson et al. 1984 ) and 305 mg/d in subjects in Auckland in 1984 .
More recently a series of studies (see later) carried out in the Department of Human Nutrition, University of Otago, in the 1990s suggested reduced I intakes reflected in lower I status as measured by urinary iodide excretion ( , 1994) .
In a combined population of blood donors residing in Otago and Waikato, the median iodide excretions for non-supplementing male and female subjects were 70 and 59 mg/d respectively, with urinary iodide concentrations of 45 and 42 mg/l. Fifty percent of the participants had a risk of mild I deficiency disorder, 35 % had moderate risk and 7 % had a risk of severe I deficiency disorder (Thomson et al. 1997a,b) according to the World Health Organization/United Nations International Children's Emergency Fund/ Centre for the Control of Iodine Deficiency Disorders (1994) criteria. Thyroid hormone concentrations (thyroid stimulating hormone, triiodothyronine, thyroxine) in the blood of all donors, however, were within normal ranges.
Similarly, in a study of pregnant and non-pregnant women, 55 % of the daily urinary excretions were , 50 mg/d, indicating moderate I deficiency . Twenty-four h urinary iodide excretion measured on twelve separate occasions over 18 months, varied considerably from month to month for each subject, but there were no obvious trends throughout the period. Mean values for daily urinary iodide and for iodide concentrations were reasonably consistent from month to month, ranging from 52 to 72 mg iodide/d and from 37 to 52 mg iodide/l respectively, with no significant differences between pregnant and non-pregnant women. Median iodide concentrations were 38 and 33 mg/l in pregnant and nonpregnant women respectively.
In a recent survey of Otago residents, low iodide excretions were confirmed (median urinary iodide concentration, 59 mg/l) and significant correlations were found between measures of urinary iodide excretion and thyroid volume and serum thyroglobulin levels (but not thyroid stimulating hormone or thyroxine). Multiple regression analysis of data for subjects divided into three groups, according to 24 h urinary iodide excretion, showed significant differences in thyroid volume and serum thyroglobulin among the groups, with those with the lowest excretions (median urinary iodide concentration, 41 mg/l) showing elevated thyroglobulin and greater thyroid volume. These results indicate that the fall in I status is being reflected in clinical measures of thyroid status, including enlarged thyroid glands and elevated thyroglobulin, suggesting a possible re-emergence of mild I deficiency in New Zealand.
In a sample of New Zealand children from Dunedin and Wellington, median urinary iodide excretion (66 mg/l) was indicative of mild I deficiency (Skeaff et al. 1999 (Skeaff et al. , 2002 . Thirty-one percent of the children had urinary iodide levels , 50 mg/l. Median urinary iodide excretion was 66 mg/l. Comparison of thyroid volume with the 2001 WHO age-and gender-specific, and age-and body surface area (BSA)-specific cut-off values (Zimmerman et al. 2001) showed that 11·3 and 12·0 % of the children respectively had thyroid gland enlargement greater than the upper limit of normal (Skeaff et al. 2002) . In the pilot of the Children's Nutrition Survey of children aged 5 -14 years carried out in New Zealand in 2000, urinary iodide excretion in casual urine samples (67 mg/l) was also indicative of mild I deficiency (Scragg & Metcalf, 2001) . This low I status (66 mg/l) was confirmed in a representative national sample in the 2002 Children's Nutrition Survey (Parnell et al. 2003) . Mild I deficiency was also found in a group of New Zealand infants and toddlers, 37 % of whom had urinary I concentrations , 50 mg/l (Skeaff et al. 2004) . When children were classified according to feeding practice, those who were currently formula-fed had significantly higher median urinary I concentration (99 mg/l) than those who were currently breast-fed (44 mg/l; P¼ 0000), indicating that infant formulas are better sources of I in New Zealand than breast milk.
Iodine status of Australians
Tasmania is the only state in Australia where there are records of I nutrition as a result of regular surveillance (Eastman, 1999) . Other data are available from the Australian Centre for the Control of Iodine Deficiency Disorders from sporadic surveys in the past 20 years of urinary iodide excretion levels in small samples of Australians (Eastman, 1999) . In the early 1990s it was reported that there was no evidence of I deficiency in any part of Australia (Eastman, 1993) . In 1992 the mean urinary iodide excretion was 180 mg/l in Sydney residents, and . 200 mg/l in Tasmanian children (Eastman, 1993) .
More recent studies in Australia, however, have shown a decreasing trend in I intakes, as is the case in New Zealand (Eastman, 1999; Gunton et al. 1999; Hynes, 2001; Li et al. 2001 ). Sporadic surveys have indicated a gradual sustained decline in urinary iodide excretion in Sydney residents (Eastman, 1999) (Table 3 ). In 1988 -99 primary-school children from Western Sydney had a median urinary iodide concentration of 84 mg/l, indicative of mild I deficiency. Similarly, in 1998 Similarly, in -99 and 2000 Similarly, in -2001 the median urinary iodide level in school-aged children in Tasmania was 75 mg/l. The I status of four groups at a Sydney hospital was determined in 1998-99 (Gunton et al. 1999; Public and Environmental Health Service, unpublished results) . Median urinary iodide concentrations were 104 mg/l in pregnant women, 79 mg/l in postpartum women, 65 mg/l in patients with diabetes mellitus and 64 mg/l in volunteers. Moderate I deficiency was found in 19 -34 % of subjects across the four groups, and mild I deficiency in an additional 30 -47 %. A more recent survey confirms the marginal I status of pregnant women (median urinary iodide excretion, 109 mg/l; McElduff et al. 2002) . As a result of these observations the Tasmanian Department of Health and Human Services mounted a survey of the urinary I status and thyroid volume of Tasmanian primary-school children (Hynes, 2001; Public and Environmental Health Service, unpublished results) . Median urinary iodide excretion of 225 children aged 4-17 years was 84 mg/l (Guttikonda et al. 2002) and the prevalence of elevated thyroid volume was 24·6 % of boys and 20·7 % for girls when compared with 2001 WHO age-and gender-specific and age-and BSA-specific cut-off values (Zimmerman et al. 2001) .
Aetiology of iodine deficiency disorders in New Zealand and Australia
Before the introduction of iodized salt in New Zealand in 1924, goitre was endemic in many parts of the country due largely to the relatively low levels of I in New Zealand soils. In 1920, the incidence of enlarged thyroid gland was approximately 32 % in schoolchildren, with a further 29 % having thyroid glands exhibiting pathological enlargement.
In 1938, the incidence of goitre in schoolchildren was 15·1 %, but by 1953 had fallen to 1·1 % (Hercus et al. 1925; Purves, 1974) . Surveys of I status in 1965 Surveys of I status in , 1982 Surveys of I status in and 1984 found that most New Zealanders had a more than adequate I status (North & Fraser, 1965; Cooper et al. 1984; Simpson et al. 1984) . Recent research, however, provides evidence of a re-emergence of mild I deficiency due to a fall in dietary I intakes (Thomson et al. 1997a; Skeaff et al. 2002) . Endemic goitre was recorded in Tasmania during the 19th century, but there are few references in the medical literature before the early 20th century (Clements & Wishart, 1956) . In 1949, goitre prevalence in schoolgirls aged 5 -17 years was 51 %, with palpable goitre being 39 % and visible goitre 12 % (Eastman, 1993) . I deficiency and goitre were also recognized in the Australian Capital Territory and surrounding districts before 1950. It was believed that the ingestion of goitrogens was a significant contributory factor in the development of endemic goitre in this area (Clements & Wishart, 1956) . Iodization of bread introduced in Tasmania in 1966 and the Australian Capital Territory in 1963, reduced the incidence of goitre but also increased the incidence of I-induced thyrotoxicosis (Tasmanian Thyroid Advisory Committee, 1981) . As in New Zealand, however, there may also be a current reemergence of I deficiency in parts of Australia (Eastman, 1999; Gunton et al. 1999; Hynes, 2001; Li et al. 2001; Guttikonda et al. 2002) due to decreasing I intakes.
Reduced I intakes in recent years are reflected in lower urinary iodide excretion in both New Zealand and Australia (Thomson et al. 1997a (Thomson et al. , 2001a Eastman, 1999; Gunton et al. 1999; Li et al. 2001; Scragg & Metcalf, 2001; Guttikonda et al. 2002; Skeaff et al. 2002; Public and Environmental Health Service, unpublished results) . Studies in New Zealand and Tasmania indicate that the fall in I status is reflected in clinical measures of thyroid status and enlarged thyroid glands (Guttikonda et al. 2002; Skeaff et al. 2002) . Groups who are likely to be at particular risk are those restricting salt intake, and those whose consumption of dairy products or fish is negligible, especially those following vegan diets. Other 'at risk' groups are pregnant and lactating women, and infants, because of the association of suboptimal intelligence development with inadequate I intake (Pharoah et al. 1984) . At present there is little evidence of any associated clinical disease. Nonetheless, it is important to continue to monitor the urinary iodide excretion of New Zealanders and Australians. It would appear to be desirable to introduce measures that increase I intakes in both countries.
The selenium -iodine interrelationship
The discovery of the role of Se in thyroid hormone production as a component of hepatic type I 5 0 -iodothyronine deiodinase, and subsequently type II and III deiodinases, presented an exciting new challenge for Se research, particularly in New Zealand where soils are relatively low in both Se and I. These enzymes catalyse the conversion of thyroxine to its active metabolite triiodothyronine. Se deficiency results in an increase in plasma thyroxine and a corresponding decrease in triidodthyronine (Arthur, 1999) . Se status may relate directly to health and wellbeing through impairment of thyroid hormone metabolism (Arthur et al. 1990 ). Goitre and hypothyroidism in rats, brought about by I deficiency, were exacerbated by concurrent Se deficiency (Arthur et al. 1990; Beckett et al. 1993 ), probably as a consequence of adverse effects of both deficiencies on thyroid hormone metabolism and on thyroid gland I content. There is increasing evidence that combined Se and I deficiencies also have significant physiological and metabolic consequences in human subjects (Corvilain et al. 1993; Vanderpas et al. 1993 ). An interaction between Se deficiency and I deficiency has been implicated in the pathogenesis of cretinism in Africa (Goyens et al. 1987) . More recently, Derumeaux et al. (2003) have shown an inverse association between Se status and thyroid volume in elderly women, but not in elderly men, participating in the SU.VI.MAX study. This suggests that Se may protect against goitre. Se also appears to be implicated in thyroid echostructure and thus may protect against autoimmune disease (Derumeaux et al. 2003) . Kvícala et al. (1995) have shown associations among measures of Se status (serum Se and urinary Se excretion) and those of thyroid status (thyroid stimulating hormone, thyroxine, triiodothyronine, thyroid volume) in a population with low Se status. Such associations might be used in the biological assessment of the magnitude of Se deficiency.
The coincidence of low-Se and low-I areas of the South Island of New Zealand is intriguing. Has the incidence of goitre in New Zealand been aggravated by low Se status? This would be difficult to investigate directly now that salt iodization has been introduced, but the nature of the relationship between Se and I is of interest, especially if the downward trend in I status continues.
Preliminary investigations in New Zealand , although not designed specifically to investigate the relationship between Se and I, showed correlation between total daily excretions of Se and I. There was also a correlation between the urinary concentrations of the two elements in fasting and in 24 h urine specimens. Similar correlations were also found in pregnant and non-pregnant women . This may merely reflect the fact that excretion of Se, and probably also that of I, is related to body size. It may, however, also reflect a relationship between the relatively low dietary intakes of the two elements in the South Island. In another New Zealand study, Se supplementation resulted in a small decline in plasma thryroxine in subjects with low Se status , as was also observed in elderly subjects in Italy (Olivieri et al. 1995) . Further studies are underway to investigate the possibility of an association among measures of Se status and of thyroid status in New Zealand.
Conclusions
The Se status of the New Zealand population remains low compared with the population of many other countries, and may still be considered marginal, although the clinical consequences of the marginal Se status are unclear. There are no recent reports of blood Se levels in Australia, but earlier reports indicate that they were generally higher than those of New Zealanders. Current recommended intakes are based on the requirement for maximal activities of the selenoprotein GPx (Standing Committee on the Evaluation of Dietary Reference Intakes of the Food and Nutrition Board, 2000; Thomson & Paterson, 2001) . The results of large cancer intervention studies currently in progress should determine whether intakes, higher than those now recommended in USA and elsewhere, are beneficial to health. Individuals may increase their Se intake by choosing high Se foods such as seafood, Brazil nuts and other good sources such as poultry and eggs (Vannoort et al. 2000) . Commercially available supplements usually contain organic Se as selenomethionine or high-Se yeast, but caution is advisable in their use to prevent unsafe high intakes.
Similarly, the consequences of decreasing I status in Australia and New Zealand are unclear. Mild I deficiency in New Zealand has resulted in enlarged thyroid glands, indicating an increased risk of goitre. Currently there is little evidence, of any associated clinical disease. Public health recommendations to reduce salt intake, however, together with the reduction in I content of dairy products, are likely to result in further decreases in the I status of New Zealand and Australian residents. Eventually some action may be necessary to prevent this decline. The consumption of rich sources of I such as eggs, fish and shellfish can be encouraged. Foods containing small quantities of seaweed, such as some types of sushi, are also effective dietary sources of I. The excessive consumption of seaweed and of I-containing dietary supplements, such as kelp tablets, is not recommended as it may lead to intakes beyond the safe upper limit. The use of iodized salt in cooking or at the table is beneficial. Advice to reduce salt intake, and the increased consumption of processed foods (in which salt is non-iodized) means that iodized salt may no longer be as effective a vehicle for I fortification as it was previously. It may be prudent now, or in the near future, for public health authorities in Australia and New Zealand to consider other foods, such as bread, as a suitable vehicle for fortification.
The consequences of possible interactions between Se and I in human nutrition are unclear, and no practical recommendations can be made. Caution is required in supplementing intakes as work from areas with severe deficiencies in Se and I indicates that Se supplementation may aggravate, rather than alleviate problems, both for children with borderline hypothyroidism and for the fetuses of pregnant mothers (Contempré et al. 1991b ). These authors have warned that any Se supplementation should not be undertaken without simultaneous I supplementation (Contempré et al. 1991a,b) .
